Study on immunological status of Chinese HIV-infected individuals

Microbiology and Immunology

Volumn 48, Issue 11, 2004, Pages 883-888

  Shang, Hong ^a   Jiang, Yongjun ^a   Zhang, Zining ^a   Han, Xiaoxu ^a   Zhang, Min ^a   Wang, Yanan ^a   Liu, Jing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Chinese; HIV; Immunological status

Indexed keywords

CYTOKINE; GAG PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6;

ARTICLE; CHINESE; CLINICAL ARTICLE; CLINICAL IMMUNOLOGY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LYMPHOCYTE COUNT; PREDICTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 10044282953     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2004.tb03606.x     Document Type: Article

References (16)

1. Altfeld, M.A., Livingston, B., Reshamwala, N., Nguyen, P.T., Addo, M.M., Shea, A., Newman, M., Fikes, J., Sidney, J., Wentworth, P., Chesnut, R., Eldridge, R.L., Rosenberg, E.S., Robbins, G.K., Brander, C., Sax, P.E., Boswell, S., Flynn, T., Buchbinder, S., Goulder, P.J., Walker, B.D., Sette, A., and Kalams, S.A. 2001. Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif. J. Virol. 75: 1301-1311.
2. Altfeld, M., Rosenberg, E.S., Shankarappa, R., Mukherjee, J.S., Hecht, P.M., Eldridge, R.L., Addo, M.M., Poon, S.H., Phillips, M.N., Robbins, G.K., Sax, P.E., Boswell, S., Kahn, J.O., Brander, C., Goulder, P.J., Levy, J.A., Mullins, J.I., and Walker, B.D. 2001. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J. Exp. Med. 193: 169-180.
3. Bartlett, J.G. 1998. Medical management of HIV infection, Port City Press, Baltimore, Md.
4. Becker, Y. 2004. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers-a review and hypothesis. Virus Genes 28: 5-18.
5. Fauci, A.S. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature 384: 529-534.
6. Giorgi, J.V., Hultin, L.E., McKeating, J.A., Johnson, T.D., Owens, B., Jacobson, L.P., Shih, R., Lewis, J., Wiley, D.J., Phair, J.P., Wolinsky, S.M., and Detels, R. 1999. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179: 859-870.
7. Goulder, P.J., Brander, C., Annamalai, K., Mngqundaniso, N., Govender, U., Tang, Y., He, S., Hartman, K.E., O'Callaghan, C.A., Ogg, G.S., Altfeld, M.A., Rosenberg, E.S., Cao, H., Kalams, S.A., Hammond, M., Bunce, M., Pelton, S.I., Burchett, S.A., McIntosh, K., Coovadia, H.M., and Walker, B.D. 2000. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. J. Virol. 74: 5679-5690.
8. Hazenberg, M.D., Otto, S.A., van Benthem, B.H., Roos, M.T., Coutinho, R.A., Lange, J.M., Hamann, D., Prins, M., and Miedema, F. 2003. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17: 1881-1888.
9. Hogan, C.M., and Hammer, S.M. 2001. Host determinants in HIV infection and disease. Ann. Intern. Med. 134: 761-776.
10. Imami, N., Pires, A., Hardy, G., Wilson, J., Gazzard, B., and Gotch, F. 2002. A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection. J. Virol. 76: 9011-9023.
11. Kelleher, A.D., Al-Harthi, L., and Landay, A.L. 1997. Immunological effects of antiretroviral and immune therapies for HIV. AIDS 11(Suppl A): S149-S155.
12. Orendi, J.M., Bloem, A.C., Borleffs, J.C., Wijnholds, F.J., de Vos, N.M., Nottet, H.S., Visser, M.R., Snippe, H., Verhoef, J., and Boucher, C.A. 1998. Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. J. Infect. Dis. 178: 1279-1287.
13. Savarino, A., Bottarel, F., Malavasi, F., and Dianzani, U. 2000. Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions? AIDS 14: 1079-1089.
14. Shearer, G.M. 1998. HIV-induced immunopathogenesis. Immunity 9: 587-593.
15. Yang, O.O., Sarkis, P.T., Trocha, A., Kalams, S.A., Johnson, R.P., and Walker, B.D. 2003. Impacts of avidity and specificity on the antiviral efficiency of HIV-1-specific CTL. J. Immunol. 171: 3718-3724.
16. Yu, X.G., Shang, H., Addo, M.M., Eldridge, R.L., Phillips, M.N., Feeney, M.E., Strick, D., Brander, C., Goulder, P.J., Rosenberg, E.S., Walker, B.D., and Altfeld, M. 2002. Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses. AIDS 16: 321-328.